Celgene Corporation Short-Term, Long-Term Guidance Up. Medium-Term? Not So Much

Celgene reported solid first-quarter earnings on Thursday, raised the low end of its 2016 guidance, and made a widely anticipated pullback to its 2017 guidance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.